Artelo Biosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARTL and other ETFs, options, and stocks.About ARTL
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal.
ARTL Key Statistics
Stock Snapshot
As of today, Artelo Biosciences(ARTL) shares are valued at $4.01. The company's market cap stands at 3.76M, with a P/E ratio of -0.08.
During the trading session on 2026-04-25, Artelo Biosciences(ARTL) shares reached a daily high of $4.24 and a low of $4.00. At a current price of $4.01, the stock is +0.2% higher than the low and still -5.4% under the high.
Trading activity shows a volume of 240.27K, compared to an average daily volume of 3.57M.
The stock's 52-week range extends from a low of $2.96 to a high of $85.80.
The stock's 52-week range extends from a low of $2.96 to a high of $85.80.
ARTL News
Artelo Biosciences (ARTL) announced the publication of a peer-reviewed article titled “Evaluating fatty acid-binding protein 5 as a therapeutic target for pain...